Precision Medicine in Inflammatory Bowel Diseases

Fischer S, Neurath M (2017)

Publication Type: Journal article

Publication year: 2017

Journal

Clinical Pharmacology & Therapeutics American Society for Clinical Pharmacology and Therapeutics

Book Volume: 102

Pages Range: 623-632

Journal Issue: 4

DOI: 10.1002/cpt.793

Abstract

Inflammatory bowel diseases (IBDs) are a lifelong condition of chronic, recurrent inflammation in the gut. The introduction of immunomodulators and biologic agents markedly improved the treatment of IBDs. Therefore, the use of biologics became an essential element in the rational therapy of IBDs. Various substances are currently evaluated in clinical trials, addressing different target structures and offering further approaches in the field of IBD. Regarding the growing number of treatment options, the need for prediction of therapy response became a necessity and is the subject of the present research.

Authors with CRIS profile

Sören Fischer Department of Transfusion Medicine and Haemostaseology Markus Neurath Lehrstuhl für Innere Medizin I

How to cite

APA:

Fischer, S., & Neurath, M. (2017). Precision Medicine in Inflammatory Bowel Diseases. Clinical Pharmacology & Therapeutics, 102(4), 623-632. https://dx.doi.org/10.1002/cpt.793

MLA:

Fischer, Sören, and Markus Neurath. "Precision Medicine in Inflammatory Bowel Diseases." Clinical Pharmacology & Therapeutics 102.4 (2017): 623-632.

BibTeX: Download